Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. ‪"Market Manipulation?" — Former SEC Official Reveals Factors Propelling Bitcoin’s Latest Price Ascent
  2. Crypto Analyst Kevin Svenson Foresees Bitcoin Skyrocketing to $70,000
  3. Analyst PlanB On How Current BTC HODLers Will Lay the Foundation for The Next Bitcoin Bull Run
  4. Markets Muted Amidst Weak PMI Readings
  5. Barbie Star's Bitcoin Remarks Ignite Discussions in Crypto World